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Scale-up of bioengineered grafts toward clinical applications is a challenge in regenerative medicine. Here, we
report tissue formation and vascularization of anatomically shaped human tibial condyles ectopically with a
dimension of 201515 mm3. A composite of poly-e-caprolactone and hydroxyapatite was fabricated using
layer deposition of three-dimensional interlaid strands with interconnecting microchannels (400 mm) and seeded
with human bone marrow stem cells (hMSCs) with or without osteogenic differentiation. An overlaying layer
(1 mm deep) of poly(ethylene glycol)-based hydrogel encapsulating hMSCs or hMSC-derived chondrocytes was
molded into anatomic shape and anchored into microchannels by gel infusion. After 6 weeks of subcutaneous
implantation in athymic rats, hMSCs generated not only significantly more blood vessels, but also significantly
larger-diameter vessels than hMSC-derived osteoblasts, although hMSC-derived osteoblasts yielded mineralized
tissue in microchannels. Chondrocytes in safranin-O-positive glycosaminoglycan matrix were present in the
cartilage layer seeded with hMSC-derived chondrogenic cells, although significantly more cells were present in
the cartilage layer seeded with hMSCs than hMSC-derived chondrocytes. Together, MSCs elaborate substan-
tially more angiogenesis, whereas their progenies yield corresponding differentiated tissue phenotypes. Scale up
is probable by incorporating a combination of stem cells and their progenies in repeating modules of internal
microchannels.
Introduction
The treatment of articular cartilage lesions, includingthose in osteoarthritis, is a major health care burden.1 A
synovial joint condyle is the bone’s articulating portion
and consists of articular cartilage that integrates with well-
organized subchondral bone. Articular cartilage consists of
chondrocytes embedded in a hydrated extracellular matrix.
Chondrocytes, despite their indispensable role in chon-
drogenesis and cartilage homeostasis, account for approxi-
mately 5% of the total cartilage volume in adults.2,3
Chondrocytes receive nutrients by diffusion exchange with
perichondrium, synovial fluid, and subchondral bone, be-
cause articular cartilage is devoid of vascular supply.3,4
These structural characteristics of articular cartilage have
ramifications in cartilage tissue engineering. First, mature
cartilage has few progenitor cells, which are critical for re-
generation.3,5–7 Second, the importance of biocompatible
polymers in cartilage regeneration is evident because ap-
proximately 95% of the adult cartilage volume is extracellu-
lar matrix.2,3 Hydrogels are hydrophilic polymers capable of
absorbing biological fluids and provide chondrocytes and=or
progenitor cells with a scaffold that simulates the cartilagi-
nous extracellular matrix.8–11 Some of the many critical dif-
ferences between articular cartilage and subchondral bone in
the context of cartilage regeneration are the obligatory role of
vascularization in bioengineered bone and the absence of
vasculature in articular cartilage.
Current therapies for late-stage osteoarthritis are primarily
total joint arthroplasty using synthetic prostheses of metal,
plastics, and ceramics. Limitations of current prostheses in-
clude infection, wear debris, aseptic loosening, dislocation,
and limited life span. The fundamental drawback of syn-
thetic prostheses is their failure to remodel with native tis-
sue.12 Existing biologically based therapies, including
autologous chondrocyte transfer and mosaicplasty, are de-
signed for localized cartilage lesions rather than as a sub-
stitute for synthetic prostheses that replace the entire
synovial joint condyle, and incomplete integration, subopti-
mal conformity of cartilage surface, altered cartilage pheno-
type, and donor site morbidity limit existing biologically
based therapies.13–16 No biologically based therapies exist for
functional replacement of the entire synovial joint condyle.
We and others have reported the tissue engineering of the
entire synovial joint condyle ectopically using cells and bio-
scaffolds.8,15,17–21 Stratified layers of cartilage and bone struc-
tures with dimensions of the human temporomandibular
joint condyles or phalangeal condyles have been formed
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ectopically in vivo from several cell sources, such as a single
population of bone marrow-derived mesenchymal stem cells
(MSCs),8,15,17–19,21,22 or differentiated chondrocytes and os-
teoblasts.21,23 Previously bioengineered joint grafts have
been limited to dimensions up to 5 to 11 mm in diameter and
3 to 7 mm in height.8,17,18,21,23 A commercially available
scaffold (20205 mm) was seeded with auricular chon-
drocytes and implanted under a vascular skin flap in vivo.24
However, cell survival may have been primarily dependent
upon the smallest Z dimension of 5 mm and the vascular-rich
environment.24 Furthermore, a microscale three-dimensional
(3D) weaving technique yielded anisotropic 3D woven
structures that were infused with a chondrocyte–hydrogel
mixture in vitro.25 There is continuing interest in cartilage
and joint regeneration using innovative approaches, but the
dimensions of all in vivo–implanted scaffolds thus far re-
ported are sufficient only for small joints such as the pha-
langes and the temporomandibular joint but not for large
joints such as the human knee and hip joints. Scale-up is a
critical roadblock in the translation of bioengineered grafts
toward clinical applications but is inevitably associated with
challenges of cell survival as well as diffusion of nutrients
and metabolic products. Vascularization is required for nu-
trient diffusion and waste removal in regenerating tissue
over a volume of 200 to 400mm.26,27 Therefore, the objective
of the present study is to determine tissue formation and
vascularization of anatomically shaped human tibial condyle
scaffolds seeded with human MSCs (hMSCs) or their chon-
drogenic and osteogenic progenies ectopically in vivo. Ac-
cordingly, we seeded human MSCs or their osteogenic
progenies in layer-by-layer fabricated scaffolds with 400-mm
interlaid strands and microchannels of a composite of poly-e-
caprolactone (PCL) and hydroxyapatite (HA). Poly(ethylene
glycol)-diacrylate (PEGDA) hydrogel (1 mm deep) encapsu-
lating hMSCs or hMSC-derived chondrogenic cells was
molded anatomically as an articular cartilage layer and in-
fused into microchannels of the PCL–HA scaffold. The
scaffold dimensions of 201515 mm3 approximately dou-
bled those in previous work8,17,18,21,23 and represent 25% of
the anatomic size of the human proximal tibial condyle,
which is also the maximum allowable implantation size in
the dorsum of athymic rats. After 6 weeks of subcutaneous
implantation, we discovered that MSCs elaborated substan-
tially more angiogenesis, whereas MSC progenies yielded
corresponding differentiated tissue phenotypes. These find-
ings have implications in synovial joint regeneration in large
animal models and patients who suffer from arthritis.
Materials and Methods
Fabrication of anatomically shaped human
tibial condyle scaffold
The anatomical contour of a native cadaver adult human
proximal tibial joint condyle (Fig. 1A) was acquired from com-
puted tomography scans and manipulated using computer-
aided design software (Rhinoceros, McNeel, Seattle, WA)
for 3D reconstruction (Fig. 1B). A scaffold was designed to
include the entire articular surface of the proximal tibial
FIG. 1. Bioengineering design of the human-shaped synovial joint condyle. The anatomical contour of a cadaver adult
human proximal tibial condyle showing medial and lateral articular surfaces (A) was captured using computed tomography
scanning and manipulated using computer-aided design for three-dimensional (3D) reconstruction (B). A composite of poly-
e-caprolactone (PCL) and hydroxyapatite (HA) was co-melted into slurry and fabricated into anatomical shape and di-
mensions using layer deposition of 3D interlaid strands with repeating microchannels (400mm) of the scaffold (C–E: sagittal,
proximal, and distal views of the fabricated scaffold, respectively). The diameter of strands and inter-strand microchannels is
400 mm (F). Color images available online at www.liebertonline.com=ten.
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condyle and subchondral bone in the dimension of 20
1515 mm3 (Fig. 1B), which equates to approximately 25% of
the anatomic size of the human proximal condyle and rep-
resents the maximum implant size allowable in the dorsum
of athymic rats. Engineering parameters were used to fabri-
cate a composite polymer scaffold (Fig. 1C–E) using layer-
by-layer deposition with a 3D printing system (Bioplotter,
EnvisionTec, Berlin, Germany). The composite consisted
of 80 wt% PCL (molecular weight (Mw) *65,000, Sigma,
St. Louis, MO) and 20 wt% of HA (Sigma, St. Louis, MO).
PCL–HA was molten in the chamber at 1208C and dispensed
through a 27-gauge metal needle (DL Technology, Haverhill,
MA) to create interlaid strands and interconnected micro-
channels (diameter 400 mm) (Fig. 1F). The scaffold was ster-
ilized in ethylene oxide for 24 h before cell seeding and in vivo
implantation.
Seeding of hMSCs and hMSC-derived osteoblasts
in scaffolds’ microchannels
hMSCs were isolated from fresh bone marrow samples of
multiple anonymous adult donors (AllCells, Berkeley, CA)
per our prior methods.17,28 Purification of hMSCs was ac-
complished by centrifugation through a density gradient
(StemCell Technologies, Vancouver, Canada) and by negative
selection following the manufacturer’s protocol to remove
hematopoietic and differentiated cells. Previously, we had
further purified similarly isolated hMSCs and differentiated
them into osteoblasts, chondrocytes, and adipocytes.17,28
Culture-expanded second- or third-passage hMSCs were
seeded at a density of 1106 cells=mL in the microchannels of
PCL–HA scaffolds (Fig. 2A). Cell suspension was repeatedly
pipetted into the microchannels for 30 min, followed by 4 h of
in vitro incubation to allow cell adhesion. Although this cell
density may be considered somewhat low for bone regener-
ation, it is anticipated that a combination of the seeded human
cells and migrated or recruited host-derived cells will con-
tribute to tissue genesis.19 A subset of PCL–HA scaffolds were
seeded with hMSCs in the scaffolds’ microchannels (Fig. 2B)
and subsequently cultured for 4 weeks in 6-well plates with
osteogenic-supplemented medium including 100 nM dexa-
methasone, 10 mM b-glycerophosphate, and 0.05 mM ascorbic
acid-2-phosphate (Sigma), until a cartilage-intended portion
was layered.
Hydrogel encapsulation of hMSCs and hMSC-derived
chondrogenic cells
PEGDA (Mw 3400; Nektar, Huntsville, AL) was dissolved
in phosphate buffered saline (6.6% w=v) supplemented with
133 U=mL of penicillin and 133 mg=mL of streptomycin (In-
vitrogen, Carlsbad, CA), and a photoinitiator (2-hydroxy-1-
[4-(hydroxyethoxy) phenyl]-2-methyl-1-propanone; 50 mg=mL;
Ciba, Tarrytown, NY). PEGDA solution suspended with
hMSCs or hMSC-derived chondrogenic cells was photo-
polymerized with a long-wavelength (365 nm) ultraviolet
light for 5 min (Glos-Mark, Upper Saddle River, NJ) in an
anatomically shaped mold of the proximal human tibial
condyle with a predefined 1-mm thickness (Fig. 2C) for im-
mersing the scaffold to allow 1-mm hydrogel depth (Fig. 2D)
and infused into the scaffolds’ microchannels. For chondro-
genic differentiation, culture-expanded second- or third-
passage hMSCs were treated in medium supplemented with
10 ng=mL of transforming growth factor beta 3 (R&D, Min-
neapolis, MN), 1% insulin-transferrin-selenium, 1% antibi-
otics, 100mg=mL of sodium pyruvate, 50 mg=mL of ascorbate,
40mg=mL of L-proline, and 100 nM dexamethasone (Sigma).
hMSCs or hMSC-derived chondrogenic cells at a density of
20106 cells=mL were separately encapsulated in PEGDA
hydrogel. This cell density was anticipated to be higher than
that in adult articular cartilage in the range of 5% to 10% of
tissue volume but was probably necessary in the early phase
of cartilage regeneration.21,23
In vivo implantation of bioengineered
osteochondral construct
Following Institutional Animal Care and Use Committee
approval by the Columbia University Medical Center,
10-week-old athymic rats (Harlan, Indianapolis, IN) were
anesthetized with 1% to 5% isoflurane. Upon disinfection
with 10% povidone iodine and 70% ethanol, a 50-mm linear
incision was made in the dorsum’s midsagittal plane. After
creation of subcutaneous pouches, the human-shaped prox-
imal tibial condyle scaffold was implanted, followed by
wound closure. One construct was implanted per rat because
the construct at a dimension of 201515 mm3 is the maxi-
mum allowable implant size in the dorsum. Cell-free scaf-
folds were implanted as controls. After 6 weeks of in vivo
implantation, all constructs were harvested upon carbon
dioxide inhalation of host rats.
Histomorphometric and immunohistochemical
analyses of in vivo bioengineered human
synovial condyle graft
The harvested tibial condyle samples were embedded in
polymethyl-methacrylate and sectioned sagittally at 5 mm
thickness (HSRL, Jackson, VA). Randomly selected sections
were stained with hematoxylin and eosin, safranin O, and
von Kossa. Blood vessel numbers and diameters, cell num-
bers per unit area, and mineralized tissue volume over total
tissue volume were quantified (Leica, Bannokburn, IL) per
our prior methods.8,29 Immunohistochemistry for type II
collagen (ab3092) and osteopontin (ab69498) was performed
per our prior methods.8,29
Data analysis and statistics
Upon confirmation of normal data distribution, all quan-
titative data of control and treated groups were treated using
one-way analysis of variance and post-hoc least significant
difference tests at an a level of 0.05 (n¼ 10 per group).
Results
Tissue formation and vascularization of in vivo
harvested bioengineered tibial condyle grafts
hMSCs seeded in the scaffolds’ microchannels (Fig. 2A)
and cultivated in vitro for 4 weeks in osteogenic stimulating
medium (Fig. 2B) attached to the microchannel wall. Upon
seeding of hMSCs or hMSC-derived chondrogenic cells in
the PEGDA hydrogel layer (Fig. 2C, D) that was infused into
the scaffolds’ microchannels, the entire osteochondral graft
was implanted subcutaneously in the dorsum of athymic
TISSUE ENGINEERING IN HUMAN-SHAPED JOINT CONDYLE 3925
rats. Harvested 6 weeks postoperatively (Fig. 2E), hydrogel
and PLC–HA portions of the osteochondral scaffold were
integrated to host tissue and maintained the original shape of
the human proximal tibial condyle (Fig. 2F). No delamina-
tion was found between the hydrogel and PLC–HA scaffold.
Freshly harvested constructs showed apparent tissue in-
growth into microchannels in the distal end of the scaffolds
(Fig. 3A–C). Microscopically, isolated areas of vasculariza-
tion were found in microchannels without any human cells
but infiltrated with host cells (Fig. 3D, G) throughout the
scaffold. In contrast, substantial vascularization was present
in microchannels of the representative scaffold seeded with
hMSCs (Fig. 3E, H). Modest vascularization was present in
the scaffolds’ microchannels seeded with hMSC-derived os-
teogenic cells (Fig. 3F, I), somewhat similar to the scaffold
without any human cells (Fig. 3D, G). Quantitatively, hMSC-
seeded scaffolds contained not only significantly more blood
vessels, but also blood vessels of significantly larger diameter
FIG. 2. Cell seeding and retrieval of in vivo implanted synovial joint condyle graft. Human mesenchymal stem cells (hMSCs)
seeded in the scaffolds’ microchannels (c.f. Fig. 1D) are attached to the surface of the microchannel wall after 4 weeks of
culture in vitro (A). Similarly, hMSCs seeded in the scaffolds’ microchannels and treated with osteogenic supplemented
medium for 4 weeks in vitro are also attached to the microchannel wall (B). Arrows in A and B indicate cell attachment.
Poly(ethylene glycol)-based hydrogel (PEGDA) (1 mm deep) encapsulating hMSCs or hMSC-derived chondrocytes, both at a
density of 20106=mL, was molded into the anatomic shape of the articular surface over the PCL–HA scaffold and was
infused into microchannels (C, and D in superior and sagittal view). Upon retrieval 6 weeks postoperatively (E), the
bioengineered tibial synovial joint condyle implant was integrated into host tissue and maintained the original shape (F). The
bioengineered cartilage layer and bone layer can be readily distinguished and yet were integrated (F). Scale for A and B:
200 mm. Color images available online at www.liebertonline.com=ten.
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than scaffolds seeded without human cells or seeded with
hMSC-derived osteogenic cells (n¼ 10; p< 0.001) (Fig. 3J).
There were no significant differences in vascular number and
diameter of scaffolds seeded without human cells or seeded
with hMSC-derived osteoblasts (n¼ 10, p> 0.05). No signif-
icant differences of tissue genesis and vascularization were
found in histomorphometry between distal, middle, and
proximal regions.
Formation of mineralized tissue
by hMSC-derived osteoblasts
After 6 weeks in vivo implantation, von Kossa staining
identified little mineralization in cell-free scaffolds, although
host cell infiltration was again evident (Fig. 4A). Despite
substantial tissue formation in hMSC-seeded scaffolds, little
mineralization was found with von Kossa staining (Fig. 4B).
In contrast, von Kossa–positive mineralization accumulated
on the surface of the scaffolds’ microchannels seeded with
hMSC-derived osteogenic cells (Fig. 4C). Osteopontin was
immunolocalized on the wall of the scaffolds’ microchannels
seeded with hMSC-derived osteoblasts (Fig. 4D), similar to
the distribution of von Kossa–positive mineral deposition in
Figure 4C. No positive osteopontin was identified in cell-free
scaffolds or hMSC seeded scaffolds (data not shown). Quan-
titatively, mineralized tissue volume per total tissue volume
in scaffolds seeded with hMSC-derived osteogenic cells was
in the range of 11.5% to 19.6% (Fig. 4E). No significant dif-
ference in mineralization was found between the distal,
middle, and proximal regions of the scaffold.
Formation of chondrogenic tissue
by hMSC-derived chondrocytes
After 6 weeks of in vivo implantation, no host cell or tissue
ingrowth was found in cell-free PEGDA hydrogel (Fig. 4F),
consistent with our previous findings.8,15,17–19,21 Abundant
cells were present in PEGDA hydrogel encapsulating hMSCs
(without chondrogenic differentiation), although safranin O
staining revealed little chondrogenesis (Fig. 4G). In contrast,
hMSC-derived chondrogenic cells seeded in PEGDA hydro-
gel yielded safranin O–positive tissue (arrows in Fig. 4H).
However, tissue inferior to safranin O–positive cells in scaf-
folds’ microchannels lacked safranin O staining (lower portion
of Fig. 4H), suggesting that hMSC-derived osteoblasts seeded
inferiorly in microchannels or host cells that had migrated into
microchannels may have prevented gel-encapsulated hMSC-
derived chondrocytes within the scaffolds’ microchannels
from undergoing chondrogenesis. Nonetheless, safranin O–
positive and –negative tissues were well integrated (Fig. 4H).
After 6 weeks of in vivo implantation, type II collagen was
immunolocalized to the pericellular matrix of hMSC-derived
chondrocytes in the PEG hydrogel layer of the osteochondral
scaffold (Fig. 4I). No positive type II collagen was identified in
cell-free PEGDA hydrogel or hMSC-seeded PEGDA hydrogel
(data not shown). There were significantly more cells in the
PEGDA hydrogel encapsulating hMSCs than hMSC-derived
chondrogenic cells after 6 weeks of in vivo implantation
(n¼ 10; p< 0.01) (Fig. 4J), suggesting that hMSCs proliferated
in PEGDA hydrogel in vivo or that perhaps hMSC-derived
chondrogenic cells proliferated less.
FIG. 3. Angiogenesis in microchannels of in vivo harvested synovial joint condyle graft. Gross images of distal ends of in vivo
retrieved condyle grafts revealed apparent tissue ingrowth into the scaffolds’ microchannels seeded without human cells (A),
hMSCs (B) and hMSC-derived osteogenic cells (hMSC-Ob) (C). Hematoxylin and eosin–stained microscopic sections showed
pronounced vascularization in a MSC-seeded graft (E, H) in comparison with modest vascularization in grafts seeded with
MSC-derived osteoblasts (F, I) or without delivered cells (cell-free) (D, G), which nonetheless was populated by host-derived
cells. Quantitatively, grafts seeded with MSCs showed not only significantly more blood vessels, but also vessels with
significantly greater diameter than MSC-Ob or cell-free samples (J) (n¼ 10; p< 0.05). There was no significant difference
in vascularization between MSC-Ob and cell-free samples (n¼ 10; p> 0.05) (G). Scale of D, E, F: 400mm, G, H, I: 200mm.
*, p> 0.05. Color images available online at www.liebertonline.com=ten.
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Discussion
The present scale-up of the human-shaped tibial joint
condyle grafts at 201515 mm3 or approximately 25% of the
proximal human tibial condyle doubles the size of our pre-
vious human-shaped temporomandibular condyle grafts.8
Modularizing large scaffolds with 400-mm repeats of micro-
channels enables scale-up because vascularization is required
for nutrient diffusion and waste removal over a volume of 200
to 400 mm.26,27 Microfabrication approaches have recently
been adopted to yield internal scaffold structures that ac-
commodate cell seeding, although scale-up of some of the
microfabricated scaffolds and in vivo performance remain to
be tested.30–32 The present approach of rapid prototyping
appears to be effective in generating repeating modulus of
400-mm microchannels that serve as conduits for vasculari-
zation and surfaces for cell seeding. We recently fabricated
hydrogels with internalized microchannels for soft tissue
applications and discovered that microchannels serve as
conduits for host-derived vascularization,33,34 similar to the
present microchannel conduits in hard tissue scaffolds. The
presently observed cell attachment to the wall of micro-
channels confirms the utility of the microchanneled scaffold.
Not only seeded human cells, but also migration and re-
cruitment of host-derived cells contribute to tissue genesis
in the scaffolds’ microchannels. To better understand the
source of host-derived cells, we are in the process of using
several cell-tracking probes, including our recently reported
FIG. 4. Histomorphometric and immunohistochemical analyses of bioengineered synovial joint condyle grafts seeded
without delivered human cells, with hMSCs, or with hMSC-derived osteogenic cells. After 6 weeks of in vivo implantation,
von Kossa staining revealed mineralized tissue accumulation on the wall of the scaffolds’ microchannels seeded with MSC-
Ob (C), in comparison with little mineralization of the graft seeded with no delivered human cells (A) or hMSCs (B).
Osteopontin, a late-stage osteogenesis marker, was immunolocalized on the surface of the microchannel wall of the repre-
sentative graft seeded with hMSC-Ob (D), corresponding to von Kossa–positive mineral deposition in C. No positive
osteopontin was identified with the cell-free PCL-HA scaffold or the hMSC-seeded PCL-HA scaffold (data not shown).
Quantitatively, bone volume per total volume in MSC-Ob–seeded grafts was in the range of 11.5% to 19.6% per image
analysis of von Kossa–stained sections (I) (n¼ 10). Safranin O, a cationic dye staining glycosaminoglycans, was positive in the
intercellular matrix of the representative graft seeded with MSC-derived chondrocytes (hMSC-Cy) (G), in comparison with
little safranin O–positive staining in representative grafts seeded with no delivered human cells (but nonetheless infiltrated
by host cells) (E) or the representative graft seeded with hMSCs (F). Type II collagen was immunolocalized to hMSC-derived
chondrocytes encapsulated in hydrogel (H). Quantitatively, significantly more cells were present in the hMSC-seeded hy-
drogel layer than hMSC-Cy (J), suggesting that MSCs are more proliferative than MSC-derived chondrocytes because the
initial cell density was equal in both groups. Scale: 400 mm (A–C, F–G), 200 mm (D, H, I). *, p< 0.01. Color images available
online at www.liebertonline.com=ten.
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bioconjugated quantum dots labeling MSCs and proge-
nies,5 to delineate the fate of delivered cells and the relative
contribution of transplanted and host cells in regenerating
tissue.
Angiogenesis is an important enabling factor for scale-up.
The observed angiogenesis in microchannels after 6 weeks of
in vivo implantation provides important clues that a probable
combination of delivered human cells and host (rat) cells
have co-populated the scaffolds’ microchannels and anasto-
mized into vasculature. Blood vessels are not only more
numerous, but also of greater diameter upon the seeding of
hMSCs than hMSC-derived osteoblasts or cell-free scaffolds,
suggesting that hMSCs, without differentiation, have the
capacity to elaborate angiogenesis and, conversely, that
hMSC progenies, such as hMSC-derived osteoblasts, are not
as capable of elaborating angiogenesis. Previous reports that
MSC-elaborated bioactive molecules increase the synthesis of
vascular endothelial growth factor and vascular density
confirm this.36,37 In the present study, not only modular
scaffolds with repeat units of internal microchannels, but
also hMSCs that elaborated angiogenesis, improved tissue
formation and vascularization.
Cell number in the bioengineered cartilage portion is sig-
nificantly greater upon seeding of hMSCs than hMSC-
derived chondrocytes. No angiogenesis is present in the
hydrogel layer that incorporates MSCs or MSC-derived
chondrocytes. What prevents angiogenesis in bioengineered
cartilage seeded with MSCs or MSC-derived chondrocytes?
An interesting observation of the present work is that hMSC-
derived chondrogenic cells seeded in PEGDA hydrogel yield
safranin O–positive tissue reminiscent of the matrix of na-
tive chondrocytes. However, tissue inferior to safranin O–
positive cells in the scaffolds’ microchannels seeded with
hMSC-derived chondrocytes lacks safranin O staining, sug-
gesting that hMSC-derived osteoblasts seeded inferiorly
in microchannels or host cells that have migrated into
microchannels prevent gel-encapsulated hMSC-derived
chondrocytes within the scaffolds’ microchannels from un-
dergoing angiogenesis. The prevention of angiogenesis in
articular cartilage has received little attention from the tissue
engineering community but is probably an important matter
that warrants additional studies.
Layer-fabricated scaffolds with repeating units of micro-
channels represent another step toward functional synovial
joint regeneration in situ by enabling scale-up of a tissue
engineering construct. This is a further extension of our
previous work31,32 using porous scaffolds fabricated with a
different rapid prototyping approach and different materials
(PCL in previous studies vs PCL–HA in the present study).
Compared with a recent study of a scale-up construct seeded
with chondrocytes in the smallest dimension of 5 mm,24 tis-
sue genesis was remarkable in the present study with the
smallest scaffold dimension of 15 mm. An important ad-
vantage of microchanneled scaffolds for synovial joint re-
generation is a balance between their mechanical stiffness
similar to bone38,39 and accommodation of cell seeding and
angiogenesis in the scaffolds’ microchannels. The present
data regarding tissue formation and vascularization in by far
one of the largest synovial joint condyle grafts in vivo suggest
that scale-up is possible by conduits of microchannels that
accommodate and enable host-derived angiogenesis and by
MSCs.
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